Table 2.
Congenital | Cyclic | Autoimmune/Idiopathic | |||||
---|---|---|---|---|---|---|---|
Age, yr | <18 | ≥18 | <18 | ≥18 | <18 | ≥18 | |
Age at presentation, yr | Median | 0.2 | 0.4 | 0.5 | 4.1 | 1.1 | 25.0 |
Mean | 0.9 | 3.4 | 1.2 | 12.6 | 1.9 | 27.8 | |
Range | (0-15.2) | (0-69.6) | (0-10.3) | (0-74.6) | (0-15.6) | (0-86.9) | |
Age at diagnosis, yr | Median | 0.5 | 1.1 | 1.3 | 11.1 | 1.4 | 28.7 |
Mean | 1.2 | 4.9 | 2.2 | 16.6 | 2.3 | 30.8 | |
Range | (0-14.5) | (0-69.7) | (0-11.5) | (0-74.6) | (0-15.9) | (0-87.0) | |
Age at start of G-CSF treatment, yr | Median | 0.9 | 7.4 | 1.6 | 21.4 | 1.7 | 33.3 |
Mean | 2.2 | 11.1 | 2.6 | 24.4 | 2.8 | 35.1 | |
Range | (0-15.2) | (0-74.3) | (0.03-10.8) | (0.1-74.6) | (0.02-16.1) | (0.1-87.5) | |
Age at enrollment, yr | Median | 2.3 | 12.8 | 2.4 | 25.7 | 2.2 | 35.7 |
Mean | 3.7 | 15.4 | 3.5 | 28.1 | 3.5 | 36.8 | |
Range | (0.1-17.7) | (0.2-74.5) | (0.4-14.6) | (1.1-75.4) | (0.4-16.7) | (1.0-87.5) |